434 Participants Needed

Reproductive Health Program for Cancer Patients

(EROS Trial)

Recruiting at 108 trial locations
Age: < 65
Sex: Female
Trial Phase: Academic
Sponsor: Eastern Cooperative Oncology Group
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This clinical trial studies reproductive health program in patients with cancer. A reproductive health program may improve patients' understanding of reproductive risks and receipt of appropriate treatment to achieve their reproductive health goals.

Who Is on the Research Team?

AP

Ashlesha Patel

Principal Investigator

Eastern Cooperative Oncology Group

Are You a Good Fit for This Trial?

This trial is for pre-menopausal women aged 15-55 with a new cancer diagnosis, including those pregnant or with DCIS. Eligible participants must have cognitive ability to engage in the study and meet specific hormonal criteria. Women who've started chemo, radiation, endocrine therapy, or had certain sterilizing surgeries can't join.

Inclusion Criteria

I am 47 or older, use hormonal birth control, and my FSH level is below 23mIU/mL.
I am mentally capable of participating in the study.
I am a woman diagnosed with any type of cancer for the first time.
See 5 more

Exclusion Criteria

I have had a hysterectomy, my ovaries removed, or been sterilized.
I have started chemotherapy, radiation, or hormone therapy before enrolling in this study.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo reproductive health program comprising didactics, reproductive health assessment and navigating algorithm, and network development

3 months
Periodic visits as per program requirements

Follow-up

Participants are monitored for safety and effectiveness after treatment

24 months
Follow-up visits at 3, 6, 12, and 24 months

What Are the Treatments Tested in This Trial?

Interventions

  • Reproductive Health Program
Trial Overview The study evaluates a reproductive health program designed to help female cancer patients understand and manage reproductive risks while pursuing their fertility goals. It includes standard practices plus training modules and referral development tailored to each patient's needs.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm B (reproductive health program)Experimental Treatment1 Intervention
Group II: Arm A (no intervention)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Eastern Cooperative Oncology Group

Lead Sponsor

Trials
272
Recruited
153,000+

ECOG-ACRIN Cancer Research Group

Lead Sponsor

Trials
122
Recruited
160,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security